WILMS' TUMOR

 

WILMS' TUMOR

 

DEFINITION:

An embryonal renal neoplasm characterized usually by an abdominal mass.

EPIDEMIOLOGY:

  • incidence: 7/million
  • prevalence: 1/12,000 live births
    • 2nd most common extracranial solid tumor in children
    • makes up 7% of all childhood cancers
  • peak age of onset:
    • 6 months - 10 years (greatest in first 5 years)
  • risk factors:
    • familial - autosomal dominant (in some families)
      • chrom.#: 11p13
      • gene: see below
    • M = F
    • most common renal cancer in children

PATHOGENESIS:

1. Background

  • tumor origin - kidney (bilateral in only 5%)
  • Wilms' tumor is a nephroblastoma which can arise by a variety of pathogenic pathways from primitive metanephric blastema
  • the gene for Wilms' tumor (WT2-1) is located at 11p13 and encodes a DNA-binding protein that is expressed primarily in the fetal kidney and in tissue that gives rise to the genitourinary system
  • inactivation of this gene may be responsible for the occurrence of a Wilms' tumor (Pritchard-Jones et al., 1990)
  • the candidate Wilms' tumor gene is predicted to encode a Kruppel-like zinc-finger protein that is probably a transcriptional factor

2. Constitutional Chromosome Abnormalities(4)

1. WAGR Syndrome

  • Wilms' tumor
  • Aniridia
    • lack or defect of the iris
  • Genitourinary Anomalies
    • gonadal dysgenesis, hypospadias, cryptorchidism, duplication of collecting system
  • mental Retardation
  • deletion of chromosome 11p13
  • tumor develops at a younger age
  • increased incidence of bilateral tumor

2. Beckwith-Wiedemann Syndrome

  • rearrangement of chromosome 11p15
  • hemihypertrophy
  • see file in database

3. Drash Syndrome

  • Wilm's Tumor
  • Nephropathy - hypertension, proteinuria, renal failure
  • Genitourinary Anomalies - ambiguous genitalia

4. Perlman Malformation Syndrome

CLINICAL FEATURES:

1. Primary Tumor

  • abdominal mass
  • abdominal pain
  • hematuria - gross or microscopic, painless, in up to 25%
  • hypertension - in 25% (due to renin-secreting tumor or renovascular hypertension)
  • others - fever, malaise, anemia, weight loss, left varicocele
  • syndromes - aniridia, hemihypertrophy, etc.

2. Metastases

  • lung (10% have mets at time of diagnosis, isolated or multiple)
  • lymph nodes
  • liver
  • brain
  • rare - bone, skin, pleura, heart, epidural space

INVESTIGATIONS:

1. Imaging Studies

1. Tumor

  • Abdominal X-Ray (rim-ring calcification), skeletal survey
  • Abdominal Ultrasound (intra- or extrarenal, uni- or bilateral, uni- or multi-focal, solid or cystic)
  • Abdominal CT
  • IVP - internal compression of calyceal system

2. For Metastases

  • Chest X-Ray
  • CT Chest

2. Pathology

1. Tumor

1. Macroscopic

  • usually confined to the kidney
  • most of affected kidney usually replaced
  • may be cystic

2. Histologic Types

1. Phasic
  • classic histology is triphasic: blastemal, epithelial, and/or stromal elements
  • constitute 90% of tumors: favourable prognosis
2. Anaplastic
  • constitute 10% of tumors: unfavourable prognosis

STAGING:

  • National Wilms' Tumor Society (NWTS)
  • Stages I -> V
  • staging system has prognostic significance

PROGNOSTIC INDICATORS:

1. Stage

  • extent of tumor

2. Histology

  • favourable or unfavourable

3. Basic Fibroblast Growth Factor (bFGF)

  • a heparin-bound blood vessel-generating peptide associated with the growth and spread of bladder, prostate, and kidney cancer
  • measured as pg/g creatinine in the urine
  • for those with Stage III or IV, preoperative bFGF levels are 25x higher than in those with Stage I or II
  • for those with persistent or recurrent Wilms' tumor, post-operative bFGF levels are 100x higher than in those who remain disease-free
  • there is a 1.6x greater chance of tumor recurrence in those with elevated postoperative bFGF levels

MANAGEMENT:

1. Surgery

  • primary and second-look operations
  • removal of involved kidney with evaluation and biospy of the opposite kidney
  • explore for extension, lymph node involvement, liver metastases

2. Chemotherapy

  • actinomycin-D (1954) and vincristine (1963) +/- doxorubicin

3. Prognosis

  • greater than 85% cure rare with current therapy
  • Stage - Cure Rate
  • I - 98%
  • II - 95%
  • III - 90%
  • IV - 80%

 

Pediatric Database - WILMS' TUMOR

Pediatric Organization - Pedbase [at] Gmail.com